Table 1.
Total patients | Cases (MYCNampRB1+/+ retinoblastoma) |
Controls (RB1-/- retinoblastoma) |
p value | |
---|---|---|---|---|
Patients n (%) | 98 | 20 (20%) | 78 (80%) | |
Female sex n (%) | 44 (45%) | 7 (35%) | 37 (47%) | .440† |
Laterality (left eye) n (%) | 49 (50%) | 9 (45%) | 40 (51%) | .803† |
Age in months at scan date; median, [IRQ], (range) | 8 [5-12], (0-67) | 7 [4-8], (3-42) | 9 [5-13], (0-67) | .059§ |
MRI examination year, median [IRQ], (range) | 2011 [2007–2015], (2001–2021) | 2014 [2009–2017], (2002–2021) | 2011 [2006–2015], (2001–2021) | .546§ |
p values were derived from † Fisher’s exact test or § Mann Whitney U –test.